Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
24.10
-1.78 (-6.88%)
At close: Mar 20, 2026, 4:00 PM EDT
24.01
-0.09 (-0.37%)
After-hours: Mar 20, 2026, 4:40 PM EDT
Greenwich LifeSciences Employees
As of December 31, 2024, Greenwich LifeSciences had 8 total employees, including 4 full-time and 4 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,434,463
Market Cap
331.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 14.29% | 4 | 4 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 3 | 4 |
| Dec 31, 2022 | 6 | 0 | - | 3 | 3 |
| Dec 31, 2021 | 6 | 3 | 100.00% | 3 | 3 |
| Dec 31, 2020 | 3 | - | - | 1 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Ginkgo Bioworks Holdings | 485 |
| 4D Molecular Therapeutics | 227 |
| Century Therapeutics | 150 |
| Aura Biosciences | 109 |
| PureTech Health | 56 |
| Shattuck Labs | 40 |
| Anavex Life Sciences | 34 |
GLSI News
- 1 day ago - Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01 - GlobeNewsWire
- 2 days ago - Greenwich LifeSciences Provides Update on Upcoming AACR Meeting - GlobeNewsWire
- 3 days ago - Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01 - GlobeNewsWire
- 4 days ago - Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01 - GlobeNewsWire
- 17 days ago - Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 - GlobeNewsWire
- 24 days ago - Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026 - GlobeNewsWire
- 7 weeks ago - Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy - GlobeNewsWire
- 2 months ago - Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 - GlobeNewsWire